Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni

Schistosoma mansoni, an intravascular parasite, lives in a hostile environment in close contact with host humoral and cellular cytotoxic factors. To establish itself in the host, the parasite has evolved a number of immune evasion mechanisms, such as antioxidant enzymes. Our laboratory has demonstra...

Full description

Bibliographic Details
Main Authors: Philip T LoVerde, Claudia Carvalho-Queiroz, Rosemary Cook
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2004-08-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000900007
_version_ 1797757119246630912
author Philip T LoVerde
Claudia Carvalho-Queiroz
Rosemary Cook
author_facet Philip T LoVerde
Claudia Carvalho-Queiroz
Rosemary Cook
author_sort Philip T LoVerde
collection DOAJ
description Schistosoma mansoni, an intravascular parasite, lives in a hostile environment in close contact with host humoral and cellular cytotoxic factors. To establish itself in the host, the parasite has evolved a number of immune evasion mechanisms, such as antioxidant enzymes. Our laboratory has demonstrated that the expression of antioxidant enzymes is developmentally regulated, with the highest levels present in the adult worm, the stage least susceptible to immune elimination, and the lowest levels in the larval stages, the most susceptible to immune elimination. Vaccination of mice with naked DNA constructs containing Cu/Zn cytosolic superoxide dismutase (CT-SOD), signal-peptide containing SOD or glutathione peroxidase (GPX) showed significant levels of protection compared to a control group. We have further shown that vaccination with SmCT-SOD but not SmGPX results in elimination of adult worms. Anti-oxidant enzyme vaccine candidates offer an advance over existing vaccine strategies that all seem to target the larval developmental stages in that they target adult worms and thus may have therapeutic as well as prophylactic value. To eliminate the potential for cross-reactivity of SmCT-SOD with human superoxide dismutase, we identified parasite-specific epitope-containing peptides. Our results serve as a basis for developing a subunit vaccine against schistosomiasis.
first_indexed 2024-03-12T18:11:22Z
format Article
id doaj.art-6e698225251043728e8ead2905b86995
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T18:11:22Z
publishDate 2004-08-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-6e698225251043728e8ead2905b869952023-08-02T09:15:31ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80602004-08-0199374310.1590/S0074-02762004000900007Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoniPhilip T LoVerdeClaudia Carvalho-QueirozRosemary CookSchistosoma mansoni, an intravascular parasite, lives in a hostile environment in close contact with host humoral and cellular cytotoxic factors. To establish itself in the host, the parasite has evolved a number of immune evasion mechanisms, such as antioxidant enzymes. Our laboratory has demonstrated that the expression of antioxidant enzymes is developmentally regulated, with the highest levels present in the adult worm, the stage least susceptible to immune elimination, and the lowest levels in the larval stages, the most susceptible to immune elimination. Vaccination of mice with naked DNA constructs containing Cu/Zn cytosolic superoxide dismutase (CT-SOD), signal-peptide containing SOD or glutathione peroxidase (GPX) showed significant levels of protection compared to a control group. We have further shown that vaccination with SmCT-SOD but not SmGPX results in elimination of adult worms. Anti-oxidant enzyme vaccine candidates offer an advance over existing vaccine strategies that all seem to target the larval developmental stages in that they target adult worms and thus may have therapeutic as well as prophylactic value. To eliminate the potential for cross-reactivity of SmCT-SOD with human superoxide dismutase, we identified parasite-specific epitope-containing peptides. Our results serve as a basis for developing a subunit vaccine against schistosomiasis.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000900007schistosomiasisDNA vaccinationantioxidantprotection
spellingShingle Philip T LoVerde
Claudia Carvalho-Queiroz
Rosemary Cook
Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni
Memorias do Instituto Oswaldo Cruz
schistosomiasis
DNA vaccination
antioxidant
protection
title Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni
title_full Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni
title_fullStr Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni
title_full_unstemmed Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni
title_short Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni
title_sort vaccination with antioxidant enzymes confers protective immunity against challenge infection with schistosoma mansoni
topic schistosomiasis
DNA vaccination
antioxidant
protection
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000900007
work_keys_str_mv AT philiptloverde vaccinationwithantioxidantenzymesconfersprotectiveimmunityagainstchallengeinfectionwithschistosomamansoni
AT claudiacarvalhoqueiroz vaccinationwithantioxidantenzymesconfersprotectiveimmunityagainstchallengeinfectionwithschistosomamansoni
AT rosemarycook vaccinationwithantioxidantenzymesconfersprotectiveimmunityagainstchallengeinfectionwithschistosomamansoni